The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
then you go to phase one which are usually about 20 to 100 people now you have your idea for how you want to make it but you don't really know the dose so you give a variety of different doses to these 20 to 100 people to see whether or not you can safely induce an immune response that you think is going to be protective based on your animal model work
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.